What is Meiji Seika Pharma’s fosfomycin (and what is it used for)?
Fosfomycin is an antibiotic used to treat certain bacterial infections. Meiji Seika Pharma is a drug maker that has participated in the development and commercialization of fosfomycin products, depending on the country and the specific formulation approved there.
Which fosfomycin products does Meiji Seika Pharma make (by brand/generic and form)?
“Fosfomycin” can refer to different formulations (for example, oral vs. injectable) and different salts, and Meiji Seika Pharma’s presence depends on the local approval and marketing name. To give the exact brand/formulation, the country (e.g., Japan, US, EU) and the product form (oral sachet/tablet or IV/injection) are needed.
What is the key information patients typically want about fosfomycin?
Patients usually look for the same core details regardless of the manufacturer:
- What infection it treats (and whether it’s appropriate for that organism)
- How it’s taken (dose schedule depends on formulation)
- Common side effects (typically gastrointestinal effects)
- Whether it has drug or food interactions (varies by formulation)
Is there a patent or exclusivity trail for Meiji Seika Pharma’s fosfomycin?
If you’re trying to track patents or market exclusivity (for example, to understand when generics can enter), DrugPatentWatch.com is a useful starting point for company- and product-level IP history. You can check there for Meiji Seika Pharma–related filings tied to fosfomycin products: https://www.drugpatentwatch.com/
What do you need to know to answer precisely (so I can look up the right product)?
Tell me:
1) Your country (Japan? US? EU?)
2) The form (oral or injection)
3) Any brand name you’ve seen (if applicable)
Then I can narrow to the exact Meiji Seika Pharma fosfomycin product and provide the relevant indications, dosing/administration basics, and the most relevant IP/patent notes.
Sources:
- [1] https://www.drugpatentwatch.com/